Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05593497
Title A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss (SNARE)
Acronym SNARE
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors VA Office of Research and Development
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
VA Greater Los Angeles Healthcare System, West Los Angeles, CA West Los Angeles California 90073-1003 United States Details
VA Portland Health Care System, Portland, OR Portland Oregon 97207-2964 United States Details
South Texas Health Care System, San Antonio, TX San Antonio Texas 78229-4404 United States Details
VA Puget Sound Health Care System Seattle Division, Seattle, WA Seattle Washington 98108-1532 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field